George W. Ebright

George W. Ebright

Keine laufenden Positionen mehr

85 Jahre
Health Technology

Profil

George W.
Ebright
has been a Director of Arrow International Inc since October 1993.
Director of Cytogen Corporation, a biopharmaceutical company engaged in the development of diagnostic and therapeutic substances for human health care applications ("Cytogen"), from February 1989 until May 1995.
Chairman of the Board of Cytogen from February 1990 until January 1995 and President from February 1989 to August 1991.
Prior thereto, President and Chief Operating Officer and a director of SmithKline Beckman Corporation, a health care and life services company engaged in the marketing of a broad line of prescription and proprietary products for human and animal health care, as well as diagnostic and analytical products and services.
From 1963 through 1987, held several senior management positions with SmithKline & French Laboratories and two of its divisions.
Director of NABI, Inc., a biopharmaceutical company which develops products for the prevention and treatment of infectious diseases, and The West Company, a supplier of specialized packaging systems to the health care and consumer products industries.

Ehemalige bekannte Positionen von George W. Ebright

UnternehmenPositionEnde
Direktor/Vorstandsmitglied 27.03.2006
Sehen Sie sich die Erfahrung von George W. Ebright im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von George W. Ebright im Detail an

Unternehmensverbindungen

Private Unternehmen1

Health Technology

  1. Börse
  2. Insiders
  3. George W. Ebright
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT